New Class of Compounds Discovered for Potential Alzheimer’s Disease Drug
Posted Aug 12 2009 10:54pm
A new class of molecules capable of blocking the formation of specific protein clumps that are believed to contribute to the dementia of Alzheimer’s disease (AD) patients has been discovered by researchers at the University of Pennsylvania School of Medicine. By assaying close to 300,000 compounds, they have identified drug-like inhibitors of AD tau protein clumping, as reported in the journal Biochemistry.Subscribe to The Alzheimer's Reading...
This is a content summary. The Performance/Comparison chart is available on the website. Hit the headline to go directly to the article. I am interested in your comments, opinion, and viewpoint.
A new class of molecules capable of blocking the formation of specific protein clumps that are believed to contribute to the dementia of Alzheimer’s disease (AD) patients has been discovered by researchers at the University of Pennsylvania School of Medicine. By assaying close to 300,000 compounds, they have identified drug-like inhibitors of AD tau protein clumping, as reported in the journal Biochemistry.Subscribe to The Alzheimer's Reading...This is a content summary. The Performance/Comparison chart is available on the website. Hit the headline to go directly to the article. I am interested in your comments, opinion, and viewpoint.